Richard Newitter
Stock Analyst at Truist Securities
(4.10)
# 540
Out of 5,012 analysts
385
Total ratings
50.22%
Success rate
13.43%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $125 → $129 | $96.79 | +33.28% | 18 | Oct 1, 2025 | |
| GKOS Glaukos | Maintains: Buy | $126 → $120 | $87.59 | +37.00% | 6 | Sep 22, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $21 → $28 | $22.13 | +26.53% | 3 | Sep 22, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $6.6 → $8 | $6.15 | +30.08% | 15 | Sep 4, 2025 | |
| MDT Medtronic | Maintains: Hold | $92 → $96 | $97.87 | -1.91% | 16 | Aug 21, 2025 | |
| CARL Carlsmed | Initiates: Buy | $18 | $13.82 | +30.25% | 1 | Aug 18, 2025 | |
| LNTH Lantheus Holdings | Downgrades: Hold | $111 → $63 | $53.55 | +17.65% | 19 | Aug 12, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $190 → $125 | $78.54 | +59.15% | 26 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Hold | $410 → $415 | $375.29 | +10.58% | 21 | Aug 4, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $145 → $137 | $105.36 | +30.03% | 8 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $81 → $82 | $75.74 | +8.27% | 19 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $600 | $448.09 | +33.90% | 29 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $24 | $15.34 | +56.45% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $102 | $67.78 | +50.49% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $365 | $315.49 | +15.69% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $68 | $60.42 | +12.55% | 27 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $128.43 | +6.67% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $70 | $34.75 | +101.44% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $51 | $34.13 | +49.43% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $18.10 | +32.60% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $14.81 | +28.29% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $179.00 | -18.99% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $98.36 | +14.88% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $258.95 | +10.06% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $15.21 | +38.07% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $8.21 | +143.61% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $76.55 | +7.12% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $193.93 | +28.91% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.13 | +529.54% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $133.09 | +478.56% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $68.34 | +24.38% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.18 | +64.20% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $17.16 | +57.34% | 5 | Feb 23, 2021 |
Boston Scientific
Oct 1, 2025
Maintains: Buy
Price Target: $125 → $129
Current: $96.79
Upside: +33.28%
Glaukos
Sep 22, 2025
Maintains: Buy
Price Target: $126 → $120
Current: $87.59
Upside: +37.00%
Beta Bionics
Sep 22, 2025
Maintains: Buy
Price Target: $21 → $28
Current: $22.13
Upside: +26.53%
Treace Medical Concepts
Sep 4, 2025
Maintains: Hold
Price Target: $6.6 → $8
Current: $6.15
Upside: +30.08%
Medtronic
Aug 21, 2025
Maintains: Hold
Price Target: $92 → $96
Current: $97.87
Upside: -1.91%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $18
Current: $13.82
Upside: +30.25%
Lantheus Holdings
Aug 12, 2025
Downgrades: Hold
Price Target: $111 → $63
Current: $53.55
Upside: +17.65%
Inspire Medical Systems
Aug 5, 2025
Downgrades: Hold
Price Target: $190 → $125
Current: $78.54
Upside: +59.15%
Stryker
Aug 4, 2025
Maintains: Hold
Price Target: $410 → $415
Current: $375.29
Upside: +10.58%
Integer Holdings
Jul 25, 2025
Maintains: Buy
Price Target: $145 → $137
Current: $105.36
Upside: +30.03%
Jul 25, 2025
Maintains: Hold
Price Target: $81 → $82
Current: $75.74
Upside: +8.27%
Jul 23, 2025
Maintains: Buy
Price Target: $590 → $600
Current: $448.09
Upside: +33.90%
Jun 16, 2025
Initiates: Hold
Price Target: $24
Current: $15.34
Upside: +56.45%
Jun 16, 2025
Initiates: Buy
Price Target: $102
Current: $67.78
Upside: +50.49%
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $315.49
Upside: +15.69%
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $60.42
Upside: +12.55%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $128.43
Upside: +6.67%
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $34.75
Upside: +101.44%
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $34.13
Upside: +49.43%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $18.10
Upside: +32.60%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $14.81
Upside: +28.29%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $179.00
Upside: -18.99%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $98.36
Upside: +14.88%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $258.95
Upside: +10.06%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $15.21
Upside: +38.07%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $8.21
Upside: +143.61%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $76.55
Upside: +7.12%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $193.93
Upside: +28.91%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.13
Upside: +529.54%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $133.09
Upside: +478.56%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $68.34
Upside: +24.38%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.18
Upside: +64.20%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $17.16
Upside: +57.34%